Freenome, Siemens Join Forces to Develop Blood Test for Breast Cancer
The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening, Fierce Biotech reports.
The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening, Fierce Biotech reports.
Brian Pilcher, PhD, discusses Conexeu’s CXU platform and what 3D-printed extracellular matrix technology could mean for future reconstructive and aesthetic surgery.